The cost of establishing and maintaining an Australian Register of a size predicted to find donors for half of the potential recipients, has been estimated at A$ 10 000 per donor procedure. The decision to proceed with unrelated bone marrow transplantation commits resources that are currently used...
The first-year costs of establishing an unrelated bone marrow donor registry are reported here. First-year costs are largely due to personnel costs and HLA typing charges. The cost per registrant decreases over time, but further decreases due to economies of scale are limited by the continued ...
Theoretically, a given synthetic bone graft should be biocompatible and well tolerated by the recipient, bioresorbable in the mid-term, easy to handle and store, and available at a reasonable cost; it should enhance bone repair and provide satisfying mechanical support. This chapter focuses on ...
We are reporting on a case of platinum-refractory low-grade ovarian cancer responding to treatment with an allogeneic bone marrow transplantation from an unrelated donor. Case. The 37-year-old patient received a preparative regimen consisting of fludarabine 25 mg/m 2 on days 6, 5, 4, 3 and...
Patients transplanted with marrow from an HLA-ABDR serologically matched unrelated donor suffer from more post-transplant complications than those who are ... M Bujanlose - 《Bone Marrow Transplant》 被引量: 168发表: 2000年 Bone marrow or peripheral blood stem cell transplantation from unrelated d...
Efficacy of donor splenocytes mixed with bone marrow cells for induction of tolerance in sublethally irradiated mice N,Narumi S,Itabashi Y, et al.Efficacy of donor splenocytes mixed with bone marrow cells for induction of tolerance in sublethally irradiated mice. Tra... N Hashimoto,S Narum...
Bone Marrow Transplantation(2014) Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision R N Lown B E Shaw Bone Marrow Transplantation(2013) Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to pr...
Introduction We hypothesized that hematopoietic stem cell (HSC) niches in bone marrow (BM) stromal environment of donor derived vascularized osteomyocutaneous allografts (VOMA) will enable sustained donor stem cell (HSC) renewal, and fac... S Tao,F Zhong,Z Hou,... - 《Transplantation》 被引量...
Antilymphocyte serum (ALS)-treated recipient mice that are infused with donor bone marrow cells have been shown to enjoy prolonged skin graft survival. In the present experiments, discontinuous density gradient centrifugation in Percoll was used to prepare fractions of these cells. Two of four fracti...
Marine collagen and marine derived bone substitutes as an alternative to autologous bone are quickly advancing, especially since the service of tissue engineering is researching biomaterial with low cost and high availability. Marine collagen should be a true alternative source of collagen. Marine species...